Clinical Trials - Phase III

Found 20,893 articles

• FDA Agrees To Special Protocol Assessment Amendment To Dendreon Corporation's D9902B 'IMPACT' Study Of PROVENGE

  11/29/2005

• Axonyx Inc. Reports Statistically Significant Result For Phenserine In Alzheimer's Disease; Additional Analysis Results From Curtailed Phase III Clinical Trials

  11/29/2005

• Aspreva Pharmaceuticals Corporation Announces Completion Of Patient Enrolment In Phase III Clinical Trial For CellCept In Myasthenia Gravis

  11/29/2005

• Actelion Ltd. Bosentan Studies In Pulmonary Fibrosis Show No Effect On Primary Exercise Improvement Endpoint

  11/28/2005

• Coley Pharmaceutical Group Announces Commencement Of Phase III Clinical Trials Of PF-3512676 For Advanced NSCLC

  11/28/2005

• BDSI Announces Its Intention To Proceed With Phase III Trials In 2006 On Its Second BEMA(TM) Product Following FDA Meeting

  11/28/2005

• Adolor Corporation Completes Enrollment In Phase 3 Study 314 Of Entereg(R) (Alvimopan) In Postoperative Ileus

  11/28/2005

• Immunomedics, Inc. Describes Alleviate Trials Design

  11/28/2005

• Alexion Pharmaceuticals Inc. Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations

  11/23/2005

• Pain Therapeutics Oxytrex Trial Fails To Cut Addiction In Statistically Meaningful Fashion

  11/22/2005

• Neurochem, Inc. Enrolls First Patient In Phase III Clinical Trial For Alzheimer's Disease In Europe

  11/22/2005

• Neurobiological Technologies, Inc. Announces Initiation Of Viprinex(TM) (Ancrod) Injection Phase III Clinical Trial For Ischemic Stroke

  11/22/2005

• Futura Medical Says Trial Results For Erectile Dysfunction Gel 'Encouraging'

  11/21/2005

• All 12-Month Follow-Up Visits Completed In OccuLogix Inc.'s Pivotal Trial For Dry Age-Related Macular Degeneration

  11/17/2005

• Tibotec Pharmaceuticals Ltd Announces Start Of TMC125 Phase III Trials

  11/17/2005

• NicOx SA Appoints PRA International, Inc. - Phase 3 Program For HCT 3012 To Be Initiated

  11/17/2005

• CV Therapeutics, Inc. Release: Data From Evaluation Of Ranolazine In Chronic Angina (ERICA) Study Presented At American Heart Association Scientific Sessions 2005

  11/17/2005

• ImClone Systems Incorporated's ERBITUX(R) Data On Locoregional Control And Overall Survival In Phase III; Drug Extends Life In Head, Neck Cancer Patients

  11/16/2005

• Biogen Idec, Inc. (California) Release: Positive Results Of Phase III Study Of Rituxan In Rheumatoid Arthritis To Be Presented At American College of Rheumatology Meeting

  11/16/2005

• Adherex Technologies Inc. Announces Global Development Plans For Advancing Eniluracil Into Phase III By Mid 2007

  11/16/2005